B20-411

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameB20-411
Drug Alias Nameangiogenesis inhibitors (Dalhousie University)B20-411
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDalhousie University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDalhousie University
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A